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image processing and atomic modeling,
refinement, and validation, the structures were
solved.
Results: Cryo-electron microscopy structures
were solved for the three-subunit PapCDKFG
complex at 5.8 Å resolution, and for the twosubunit PapCDKG complex at 3.8 and 7.2 Å
resolution, respectively.
Conclusion: Our cryo-EM structures show
processive steps in P pilus biogenesis, reveal
differences between P and type 1 pili, and capture
new conformational dynamics of the usher
assembly machine. We present here the first
structures of the activated PapC usher captured
during the pilus assembly process. These
structures pave the way for novel therapeutics
designed against P pili and other virulence factors
assembled by the CU pathway, which may provide
alternatives to the use of antibiotics in the
treatment of urinary tract infections and other
infectious diseases.
Funding: F30AI112252 (GW); R01GM062987
(DT)
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Introduction: Polymerase chain reaction (PCR)
has been shown to be more sensitive in the
detection of polymicrobial infections in patients
with urinary tract infection (UTI). Bacterial
consortia are non-random communities of
microbes that may act synergistically to provide
growth and survival advantages. We aim to
investigate the relationship between bacteria
detected by PCR, and the presence of consortia,
with clinical findings in patients with symptomatic
UTI.
Methods: We performed a retrospective analysis
of 2493 UTI-symptomatic patients over the age of
60 from 37 geographically disparate urology clinics
in the U.S. from July 2018 to February 2019.
Clinical findings, including UA dipstick results and
UTI symptoms, were recorded. Multiplex PCR (MPCR) was performed to detect 24 different
bacterial species in the urine specimens. A cutoff
of 10 detections was used to distinguish a
bacterial consortium from a random association of
bacteria in a polymicrobial specimen. Summary
statistics and Kruskal-Wallis test were used to
compare the mean numbers of clinical findings
across different number of bacterial species within
a bacterial consortium.
Results: Bacteria were detected in 69%
(1710/2493) of patients. Among these,
monomicrobial infections were found in 40%
(683/1710), and polymicrobial infections were
found in 60% (1027/1710). Among the
polymicrobial infections, consortia were identified
in 433 specimens. Consortia polymicrobial urine
specimens had more clinical findings than
monomicrobial specimens, 2.84 vs. 2.66,
respectively (p=0.022). The more bacteria
detected within a consortium, the more clinical
findings were reported (p=0.026), Table 1. Among
consortia polymicrobial specimens, specimens
containing Gram-negative bacteria were
associated with a higher number of clinical
findings compared to specimens without Gramnegative bacteria, 3.21 vs. 2.52, respectively
(p<0.0001).
Conclusion: Consortia polymicrobial UTIs were
associated with more clinical findings than
monomicrobial infections. The number of clinical
findings also increased with increasing numbers of
bacteria within a consortium. The identification of a
consortium within polymicrobial UTIs and the
correlation of clinical findings may be important for
understanding the treatment of polymicrobial UTIs.
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Introduction: Studies have shown many genes
influence antibiotic resistance, and the relationship
between genotypic and phenotypic antibiotic
resistance is unclear. We sought to analyze the
concordance between the presence of antibiotic
resistance (ABR) genes and antibiotic
susceptibility results in urine samples collected
from symptomatic UTI patients.
Methods: Urine samples were collected from
patients presenting with possible UTI to 37
geographically disparate Urology clinics from July
2018 to February 2019. Multiplex polymerase

chain reaction (M-PCR) was used to test for 33
different ABR genes. Samples in which at least
one organism was identified at a quantity of ≥104
cells per mL, Pooled Antibiotic Susceptibility
Testing (P-AST), which involves simultaneously
growing all detected bacteria together in the
presence of antibiotics and then measuring
susceptibility, was performed against 14 different
antibiotics. The concordance rate between the
ABR genes and the P-AST results was generated
for the overall group. The concordance rates for
each antibiotic between monomicrobial and
polymicrobial infection were compared using chisquare test.
Results: Among the 2,512 patients, bacteria were
detected in 1,579. ABR gene genotyping and PAST analysis was performed for 1,155. ABR
genes were detected in 36.3% (419/1155) of
specimens. Overall, the presence or absence of
ABR genes was 60% concordant with antibiotic
susceptibility patterns. Two circumstances
accounted for the concordance: ABR gene not
present by M-PCR/antibiotic sensitive by P-AST
(48.4%) and ABR gene present/antibiotic resistant
(11.5%). In the 40% non-concordant cases, 25%
were ABR gene not present/antibiotic resistant
and 15% were ABR gene present/antibiotic
sensitive, Table 1. Most antibiotics were
associated with similar concordance rates for
monomicrobial and polymicrobial infections.
However, the concordance rates were significantly
lower for polymicrobial for three antibiotics:
vancomycin, meropenem, and
piperacillin/tazobactam, with absolute differences
of 9.3% (p value=0.002), 13.1% (p value<0.0001),
and 19.0% (p value = 0.019), respectively.
Conclusion: The concordance rate of the ABR
genes as identified by M-PCR and phenotypic
resistance as detected by P-AST was 60%. Thus,
in 40% of samples, the reliance on the M-PCR
antibiotic resistance gene report without the
phenotypic data reported by P-AST data may lead
to inappropriate treatment.
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